$2.01
0.09[4.69%]
At close: Apr 25
$2.01
0[0.00%]
After Hours: 4:04PM EDT
Athira Pharma
(NASDAQ:ATHA)Athira Pharma Stock (NASDAQ:ATHA), Insider Trading Activity
Athira Pharma: Insider buying and selling updated today.
Insider Shares Owned
1.939M
Insider Percentage Owned
5.06%
Institutional Shares Held
5.507M
Institutional Percentage Held
14.4%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08, 2024 | Andrew Gengos | SEE BELOW | 3.792K | $2.91 | -$3.52K | GRANT | 4.74% | 83.804K | Jan 04 - Jan 05 | View |
| Jan 08, 2024 | Mark Litton | CHIEF EXECUTIVE OFFICER | 15.18K | $2.91 | -$14.03K | GRANT | 11.18% | 150.96K | Jan 04 - Jan 05 | View |
| Jan 08, 2024 | Mark Worthington | GENERAL COUNSEL | 15.355K | $2.66 | $11.70K | GRANT | 80.41% | 34.452K | May 18 - Jan 05 | View |
| Jan 08, 2024 | Kevin Church | CHIEF SCIENTIFIC OFFICER | 11.794K | $2.23 | -$517.25 | GRANT | 17.23% | 80.256K | Jan 04 - Nov 20 | View |
| Jan 08, 2024 | Rachel Lenington | CHIEF OPERATING OFFICER | 7.588K | $2.91 | -$7.02K | GRANT | 130.67% | 13.395K | Jan 04 - Jan 05 | View |
| Dec 29, 2023 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 605.686K | $2.42 | $1.46M | BUY | 12.63% | 5.402964M | Dec 27 - Dec 29 | View |
| Jun 09, 2023 | Andrew Gengos | SEE BELOW | 15K | $3.43 | $51.45K | BUY | 23.07% | 80.012K | Jun 07 | View |
| Jun 06, 2023 | Andrew Gengos | SEE BELOW | 65.012K | $2.95 | $191.57K | BUY | ∞ | 65.012K | Jun 02 - Jun 05 | View |
| Mar 31, 2023 | Grant Pickering | DIRECTOR | 25K | $2.41 | $60.35K | BUY | 3192.85% | 25.783K | Mar 29 - Mar 30 | View |
| Mar 30, 2023 | James A Johnson | DIRECTOR | 5K | $2.40 | $12.00K | BUY | ∞ | 5K | Mar 29 | View |
| Dec 30, 2022 | Glenna Mileson | CHIEF FINANCIAL OFFICER | 50.763K | $2.84 | $144.34K | BUY | 46.50% | 159.93K | Nov 18 - Dec 28 | View |
| Dec 06, 2022 | Kelly A Romano | DIRECTOR | 30K | $3.29 | $98.70K | BUY | 360.79% | 38.315K | Dec 02 | View |
| Nov 17, 2022 | Hans Moebius | CHIEF MEDICAL OFFICER | 5K | $3.29 | $16.44K | BUY | 8.22% | 65.836K | Nov 15 | View |
| Jul 01, 2022 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 1.371362M | $2.99 | $4.10M | BUY | 40.03% | 4.797278M | Jun 29 - Jun 30 | View |
| Jun 30, 2022 | Hans Moebius | CHIEF MEDICAL OFFICER | 10K | $2.88 | $28.80K | BUY | 23.28% | 52.955K | Jun 28 | View |
| Jun 24, 2022 | Mark Worthington | GENERAL COUNSEL | 10.782K | $4.88 | $16.94K | GRANT | 129.67% | 19.097K | May 18 - Jun 23 | View |
| Jun 24, 2022 | Glenna Mileson | CHIEF FINANCIAL OFFICER | 9.107K | $4.88 | $5.12K | GRANT | 9.10% | 109.167K | May 18 - Jun 23 | View |
| Jun 24, 2022 | Mark Litton | CHIEF EXECUTIVE OFFICER | 12.797K | $4.88 | -$16.07K | GRANT | 10.46% | 135.118K | May 18 - Jun 23 | View |
| Jun 24, 2022 | Rachel Lenington | CHIEF OPERATING OFFICER | 5.807K | $2.69 | -$11.28K | GRANT | ∞ | 5.807K | Jun 22 - Jun 23 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.